| Retinal Diseases and Treatments | Lifetime | 53 | FI 1 | 99.69 |
| Autophagy in Disease and Therapy | Lifetime | 47 | FI 1 | 99.61 |
| Sirtuins and Resveratrol in Medicine | Lifetime | 47 | FI 2 | 98.60 |
| Ocular Diseases and Behçet’s Syndrome | Lifetime | 110 | FI 1 | 98.82 |
| Inflammasome and immune disorders | Lifetime | 209 | FI 2 | 97.72 |
| Endoplasmic Reticulum Stress and Disease | Lifetime | 286 | FI 5 | 97.93 |
| Advanced Glycation End Products research | Lifetime | 184 | FI 2 | 97.28 |
| Heat shock proteins research | Lifetime | 237 | FI 2 | 97.15 |
| Retinal Imaging and Analysis | Lifetime | 460 | FI 2 | 97.70 |
| Glaucoma and retinal disorders | Lifetime | 983 | FI 7 | 97.83 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 910 | FI 6 | 97.24 |
| Heme Oxygenase-1 and Carbon Monoxide | Lifetime | 340 | FI 2 | 96.30 |
| Retinal Development and Disorders | Lifetime | 730 | FI 2 | 96.65 |
| Genomics, phytochemicals, and oxidative stress | Lifetime | 656 | FI 7 | 94.95 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | Lifetime | 669 | FI 3 | 94.87 |
| Genetics, Aging, and Longevity in Model Organisms | Lifetime | 644 | FI 3 | 94.27 |
| Ocular Surface and Contact Lens | Lifetime | 908 | FI 6 | 95.41 |
| thermodynamics and calorimetric analyses | Lifetime | 569 | FI 3 | 90.68 |
| Flavonoids in Medical Research | Lifetime | 346 | FI 1 | 86.44 |
| Calcium signaling and nucleotide metabolism | Lifetime | 940 | FI 6 | 84.81 |
| Nasolacrimal Duct Obstruction Treatments | Lifetime | 675 | FI 4 | 68.10 |
| Natural Compounds in Disease Treatment | Lifetime | 893 | FI 3 | 61.08 |
| Retinal Diseases and Treatments | 2021-2025 | 26 | FI 1 | 99.48 |
| Autophagy in Disease and Therapy | 2021-2025 | 34 | FI 1 | 97.88 |
| Retinal Imaging and Analysis | 2021-2025 | 112 | FI 1 | 97.73 |
| Ocular Diseases and Behçet’s Syndrome | 2021-2025 | 71 | FI 1 | 96.47 |
| Glaucoma and retinal disorders | 2021-2025 | 697 | FI 3 | 92.94 |
| Retinal Development and Disorders | 2021-2025 | 575 | FI 4 | 84.97 |
| Advanced Glycation End Products research | 2021-2025 | 234 | FI 1 | 81.61 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | 2021-2025 | 373 | FI 1 | 81.52 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 318 | FI 1 | 71.84 |
| Heme Oxygenase-1 and Carbon Monoxide | 2021-2025 | 651 | FI 3 | 65.61 |
| Calcium signaling and nucleotide metabolism | 2021-2025 | 444 | FI 2 | 54.66 |
